Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Definitive Healthcare (DH) Other Non-Current Assets (2020 - 2025)

Definitive Healthcare (DH) has disclosed Other Non-Current Assets for 6 consecutive years, with $2.3 million as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Other Non-Current Assets fell 1.0% year-over-year to $2.3 million, compared with a TTM value of $2.3 million through Dec 2025, down 1.0%, and an annual FY2025 reading of $2.3 million, down 1.0% over the prior year.
  • Other Non-Current Assets was $2.3 million for Q4 2025 at Definitive Healthcare, up from $1.8 million in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $8.4 million in Q4 2021 and bottomed at $747000.0 in Q3 2021.
  • Average Other Non-Current Assets over 5 years is $3.1 million, with a median of $2.7 million recorded in 2022.
  • The sharpest move saw Other Non-Current Assets soared 583.4% in 2022, then tumbled 50.58% in 2024.
  • Year by year, Other Non-Current Assets stood at $8.4 million in 2021, then tumbled by 44.45% to $4.7 million in 2022, then tumbled by 49.01% to $2.4 million in 2023, then dropped by 3.69% to $2.3 million in 2024, then decreased by 1.0% to $2.3 million in 2025.
  • Business Quant data shows Other Non-Current Assets for DH at $2.3 million in Q4 2025, $1.8 million in Q3 2025, and $2.6 million in Q2 2025.